Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med
; 389(2): 137-147, 2023 Jul 13.
Article
in En
| MEDLINE
| ID: mdl-37272535
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
COVID-19
/
Lung Neoplasms
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2023
Type:
Article